The Corporate Antibody: How Big Companies Kill Innovation (And What Actually Works)

Every Fortune 500 company says they want to work with startups. Almost none of them actually can. The problem isn't intention. It's infrastructure. When a corporation scales, it builds immune systems—legal, compliance, IT, procurement—designed to protect the core business. Those same systems treat startups like viruses. A startup can build a prototype in the time it takes a corporation to schedule the meeting to discuss building one. The corporate entry point is procurement. The startup's frame is survival. The risk profiles don't align. The cadences don't match. And after 25 years of watching this pattern repeat, the infrastructure to make it work simply doesn't exist. Until now. In this episode, Kevin McGinnis sits down with a corporate innovation veteran who spent years inside Sprint driving open innovation strategy, building accelerator programs, and watching promising startup relationships die in legal review. But more importantly: he's spent the last several years designing the actual infrastructure that makes corporate-startup alignment work at scale. He reveals why "sponsored happy hours" and "innovation challenges" fail. Why the entry point matters more than the intention. And why one structural change—a reverse pitch, where corporations bring real problems instead of startups pitching solutions—completely transforms engagement from transactional to transformational. This is systems design thinking applied to one of the region's biggest untapped opportunities: corporations and startups learning to work together.